02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
With the spread of coronavirus, many home buyers are living in a state of uncertainty. What happens ...
Read More >
There is perhaps no more consistently vexing problem for transactional attorneys on opposite sides t...
Read More >
With data privacy issues constantly in the news, what do businesses need to know about handling pers...
Read More >
The Financial Services Regulatory Authority of Ontario (FSRA) has announced a “one-time opportunity...
Read More >
After watching The Irishman on Netflix, I’m left with two overriding thoughts: One, my God, that’s...
Read More >
In today’s edition of Daily Compliance News: • One of the country’s top border officers cannot s...
Read More >